| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/19/2009 | US20090048204 Novel forms of cddo methyl ester |
| 02/19/2009 | US20090048202 Selective inhibitors of translesion dna replication |
| 02/19/2009 | US20090048201 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 02/19/2009 | US20090048192 Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation |
| 02/19/2009 | US20090048187 Chemopreventive, Anticancer and Anti-Inflammatory Effects of Pinoresinol-Rich Olives |
| 02/19/2009 | US20090048179 Use of 5-phosphodiesterase inhibitors to enhance the permeability of the blood-brain barrier of abnormal brain tissue and the blood-tumor barrier |
| 02/19/2009 | US20090048175 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 02/19/2009 | US20090048174 Methods for inhibiting angiogenesis and tumor growth by inhibition of beta or delta protein kinase C |
| 02/19/2009 | US20090048156 Hdac inhibitors and hormone targeted drugs for the treatment of cancer |
| 02/19/2009 | US20090048151 PEG-Poly(Ortho Ester) Graft Copolymers and Pharmaceutical Compositions |
| 02/19/2009 | US20090048148 Compositions and methods for therapeutic use |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | US20090047356 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports; antitumor agents; kits |
| 02/19/2009 | US20090047306 Adjuvant compositions |
| 02/19/2009 | US20090047296 Antibodies conjugated to Auristatin analogs via a maleimidocaproyl lingages; for treating cancer, autoimmune diseases and infectious diseases |
| 02/19/2009 | US20090047288 Glucan compositions and methods of enhancing CR3 dependent neutrophil-mediated cytotoxicity |
| 02/19/2009 | US20090047270 Enzymatic anticancer therapy |
| 02/19/2009 | US20090047268 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof |
| 02/19/2009 | US20090047250 Methods for treating or preventing neuroinflammation or autoimmune diseases |
| 02/19/2009 | US20090047243 Combinations for the treatment of b-cell proliferative disorders |
| 02/19/2009 | US20090047240 Chaperonin 10-induced immunomodulation |
| 02/19/2009 | US20090047221 Compounds and compositions useful in the treatment of neoplasia |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | US20090047213 Cytotoxicity mediation of cells evidencing surface expression of CD59 |
| 02/19/2009 | US20090047212 Urothelial differentiation of urothelial carcinoma: a bladder cancer stem cell model |
| 02/19/2009 | DE102007038957A1 6-Thioxo-pyridazinderivate 6-thioxo-pyridazine derivatives |
| 02/19/2009 | CA2736382A1 Synergistic pharmaceutical composition useful for inhibiting corneal and retinal neovascularization (angiogenesis), and in other organs, in a human being or animal |
| 02/19/2009 | CA2733676A1 Microrna compositions and methods for the treatment of myelogenous leukemia |
| 02/19/2009 | CA2733672A1 Tumor cell-derived microvesicles |
| 02/19/2009 | CA2696360A1 Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof |
| 02/19/2009 | CA2696330A1 Novel forms of cddo methyl ester |
| 02/19/2009 | CA2695981A1 Vhz for diagnosis and treatment of cancer |
| 02/19/2009 | CA2695977A1 Tricyclic amide compound |
| 02/19/2009 | CA2695956A1 Substituted hydantoins |
| 02/19/2009 | CA2695878A1 5-membered heterocyclic compound |
| 02/19/2009 | CA2695753A1 Compounds useful as protein kinases inhibitors |
| 02/19/2009 | CA2695475A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/19/2009 | CA2695251A1 Fused imidazoles for cancer treatment |
| 02/19/2009 | CA2694666A1 Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents |
| 02/19/2009 | CA2694058A1 Fused bicyclic pyrimidines |
| 02/19/2009 | CA2693162A1 Heterocyclic compounds and uses as anticancer agents |
| 02/19/2009 | CA2691593A1 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | CA2691586A1 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/18/2009 | EP2025686A2 Alpha anticholine kinase monoclonal antibodies and their use in analytical techniques for the diagnosis of cancer and the preparation of medicinal products |
| 02/18/2009 | EP2025682A2 Human endokine alpha |
| 02/18/2009 | EP2025678A1 Pyrazolo[3,4-d]pyrimidine compounds and their use as modulators of protein kinase |
| 02/18/2009 | EP2025676A1 Novel indazole derivative having spiro ring structure in side chain |
| 02/18/2009 | EP2025666A2 Thiolalkyl benzoic acid derivatives |
| 02/18/2009 | EP2025661A1 Fluoroalkyloxy-containing combretastatin derivatives, preparation and use thereof |
| 02/18/2009 | EP2025348A1 Targeted block copolymer micelles |
| 02/18/2009 | EP2025347A1 Prophylactic and therapeutic agent for cancer |
| 02/18/2009 | EP2025344A1 Melanoma Therapy |
| 02/18/2009 | EP2025343A1 A short-chain peptide anti-cancer drug and its use |
| 02/18/2009 | EP2025339A1 WATER SOLUTION OF 20(R)-GINSENOSIDE Rg3 PHARMACEUTICAL COMPOSITION AND PROCESS THEREOF |
| 02/18/2009 | EP2024372A2 Thieno [3,2-d] pyrimidine derivative useful as pi3k inhibitor |
| 02/18/2009 | EP2024370A1 Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes |
| 02/18/2009 | EP2024366A2 Monocyclic heteroaryl compounds |
| 02/18/2009 | EP2024362A1 Iap bir domain binding compounds |
| 02/18/2009 | EP2024353A2 Pyrazole compounds |
| 02/18/2009 | EP2024335A1 Novel imidazole derivatives, preparation and user thereof as medicine |
| 02/18/2009 | EP2023960A1 Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same |
| 02/18/2009 | EP2023956A2 Pharmaceutical combinations comprising a mtor inhibitor and a raf kinase inhibitor |
| 02/18/2009 | EP2023949A2 Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics |
| 02/18/2009 | EP2023933A2 Acetylenic heteroaryl compounds |
| 02/18/2009 | EP2023931A2 Anticancer treatments with a combination of docetaxel and ecteinascidin |
| 02/18/2009 | EP2023925A2 Cdki pathway inhibitors as selective inhibitors of tumor cell growth |
| 02/18/2009 | EP2023922A2 Triazole derivatives ii |
| 02/18/2009 | EP2023915A2 Borrelidin derivatives as antiproliferative agents and angiogenesis inhibitors |
| 02/18/2009 | EP2023912A2 Methods and compositions using immunomodulatory compounds in combination therapy |
| 02/18/2009 | EP2023911A2 Compounds a-r-x for the manufacture of pharmaceutical preparations |
| 02/18/2009 | EP2023910A1 Ah receptor antagonists |
| 02/18/2009 | EP2023813A2 Magnetic microparticles comprising organic substances |
| 02/18/2009 | EP2023720A2 Tetracyclic imidazole analogs |
| 02/18/2009 | EP1902054B1 Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof and the therapeutic application of the same |
| 02/18/2009 | EP1658255B1 Proteasome inhibitors and methods of using the same |
| 02/18/2009 | EP1658068B1 Novel cycloalkyl[b] condensed indoles |
| 02/18/2009 | EP1614684B1 Diamine derivative, production process, and antioxidizing drug |
| 02/18/2009 | EP1539727B1 Compounds, compositions, and methods for treating cellular proliferative diseases |
| 02/18/2009 | EP1458757B1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 02/18/2009 | EP1444210B1 Qunazoline derivatives as antitumor agents |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1366063B1 Inhibitors of lyn-associated signal transduction (last) and the use thereof in the treatment of prostate cancer |
| 02/18/2009 | EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
| 02/18/2009 | EP1135467B1 Psca: prostate stem cell antigen and uses thereof |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | EP0969866B2 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 02/18/2009 | CN101371142A Method of diagnosis and method of treatment |
| 02/18/2009 | CN101370830A Human monoclonal antibodies to CD70 |
| 02/18/2009 | CN101370814A Solid forms of a pyrrolopyrimidine derivative and their use as anti-tumor agents |
| 02/18/2009 | CN101370813A Dimers and adducts of 6-[substituted) phenyl] triazolopyrimidines useful as anticancer agents |
| 02/18/2009 | CN101370811A Imidazopyrazines as protein kinase inhibitors |
| 02/18/2009 | CN101370804A Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 02/18/2009 | CN101370803A Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370794A Chemical compounds |
| 02/18/2009 | CN101370791A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370790A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370789A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370784A Polycyclic indazole derivatives that are erk inhibitors |